We are live on ! Find out more
SYNB

Putnam BioRevolution ETF
SYNB

Delisted

SYNB was delisted on the 13th of November, 2025.

Back to rankings

4 hedge funds and large institutions have $3.72M invested in Putnam BioRevolution ETF in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more funds holding

Funds holding: 1 → 4 (+3)

79.53% more ownership

Funds ownership: 0% → 79.53% (+80%)

20% more capital invested

Capital invested by funds: $3.1M → $3.72M (+$618K)

Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$463K
2
UBS Group
UBS Group
Switzerland
+$6.69K
3
Osaic Holdings
Osaic Holdings
Arizona
+$1.04K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$3.25M – – –
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$464K +$463K +17,858 New
UBS Group
3
UBS Group
Switzerland
$6.7K +$6.69K +258 New
Osaic Holdings
4
Osaic Holdings
Arizona
$1K +$1.04K +40 New

SYNB Hedge Fund Activity: Q4 2022 in Review

4 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q4 2022, worth a combined $3.72M — up 20% from $3.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new SYNB positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Royal Bank of Canada, opening a new position worth an estimated $463K.

  • 4 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q4 2022, up from 1 in Q3 2022.
  • Funds reported $3.72M of Putnam BioRevolution ETF stock for Q4 2022, up 20% quarter-over-quarter.
  • 3 funds opened new Putnam BioRevolution ETF positions in Q4 2022 and 0 closed out, a net change of +3 holders.
  • The largest Putnam BioRevolution ETF buyer in Q4 2022 was Royal Bank of Canada, an estimated $463K added.

Based on aggregated 13F filings for Q4 2022.